News

In the European Union and the United Kingdom, aflibercept 8 mg (Eylea HD in the US) is currently approved for neovascular age-related macular degeneration and diabetic macular oedema

A Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 was set by the organization.

A Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025, was set by the organization.

Social determinants of health challenge our existing expectations

Patients with GCA, an autoimmune disease, are at risk for sudden vision loss which can be permanent

The new data builds upon previously reported 6- and 12-month positive results from adult patients treated in the same study.

Good safety profile and “meaningful improvement” in vision in Leber congenital amaurosis patient.

BRIMOCHOL PF’s combination of brimonidine and carbachol produces a “pinhole effect,” which is intended to improve depth of focus and sharpen near and distant impact.

Following Phase 3 pivotal trial BRIO-II, Tenpoint Therapeutics said they hope to launch BRIMOCHOL PF in 2026

Katrina Ronne shares her vision to empower ophthalmologists, champion equity, and strengthen advocacy for better eye health outcomes across Australia.

Although it improved interdisciplinary communication, ongoing review and safety monitoring are necessary for successful clinical implementation.

A study found that children with early-onset atopic dermatitis have a higher risk of developing uveitis and should be closely monitored for its onset.

The study findings support the need to consider ophthalmologic monitoring in children with early-onset atopic dermatitis

Each company will hold a respective special meeting of stockholders to vote on the approval of the merger.

Nordic Pharma plans to announce commercialization details in the near future for the dry eye disease treatment

A study found that children with early-onset atopic dermatitis have a higher risk of developing uveitis and should be closely monitored for its onset.

Tapcom is a preservative-free, fixed-combination eye drop of tafluprost 0.0015% and timolol 0.5% for lowering intraocular pressure.

Nordic Pharma plans to announce commercialisation details in the near future for the dry eye disease treatment

In celebration of Ophthalmology Times' 50th anniversary, we asked leading experts in the field what they see as the biggest innovation in ophthalmology in the past 5 decades.

The novel corrective eye drop can be prescribed through pharmacy partners BlinkRx or Medvantx

Researchers from the Czech Republic found that an AI system showed higher sensitivity and specificity for screening diabetic retinopathy compared to telemedicine evaluations.

Fundus images of diabetic retinopathy were assessed by general ophthalmologists, retina specialists and the Aireen artificial intelligence system

In celebration of Ophthalmology Times 50th anniversary, we asked leading experts in the field what they see as the biggest innovation in ophthalmology in the last 5 decades.

Tertiary syphilis, which can develop years to decades after the initial infection, is characterized by chronic inflammatory damage affecting multiple organ systems.

Treatment regimens with long-duration therapies continue to be a conversation starter among retina specialists

The Congress on Controversies in Ophthalmology highlights debates, but also discussions

The first session of the 2025 COPHy meeting was titled "Big controversies in retina and beyond in 2025.”

Researchers from the Czech Republic found that an AI system showed higher sensitivity and specificity for screening diabetic retinopathy compared to telemedicine evaluations.